Most Commented
- Cubadebate opens its new Web page in English| 20
- Mandela is dead: Why hide the truth about Apartheid?| 11
- El Paso Diary: The Battle Over the Solo Fax| 10
- President Hugo Chavez's address to the People of Venezuela| 10
- Free the Five is heard at Left Forum| 6
- May every citizen be a constituent| 6
- Raúl receives Kim Yong Chol, Special Envoy of the President of the Workers’ Party of Korea| 6
- The Unsustainable Position of the Empire| 5
- U.S. government promoting Internet aggression against Cuba| 5
- NATO’s Genocidal Role| 4
- The Fiftieth Anniversary Parade| 4
- El Paso Diary: The Tip of the Iceberg| 4
Series
- Cuba's Reasons
- Cuban Five
- El Paso Diary
The El Paso Diary is written by José Pertierra--an attorney who represents the government of Venezuela in its request for the extradition of Luis Posada Carriles. Pertierra´s journals describe the testimony, evidence, legal skirmishes, quirks and follies of this very historic trial that features for the first time the close collaboration of the United States government with Cuban authorities to prosecute an ex CIA agent who is one of the masterminds of the fifty-year old dirty war against Cuba.
Authors
- Bernie Dwyer
- Bruno Rodríguez Parrilla
- Deisy Francis Mexidor
- Fidel Castro Ruz
- José Pertierra
- Raúl Castro Ruz
- Ricardo Alarcón de Quesada
- Amy Goodman
- Arleen Rodríguez Derivet
- Frei Betto
- Hugo Chávez Frías
- Josh R. Nelson
- Juan Gelman
- Luis Rumbaut
- Michael Moore
- Mumia Abu-Jamal
- Noam Chomsky
- Reinaldo Taladrid Herrero
- Richard Gott
- Tom Hayden
Articles of Science
News »
New horizons for science and innovation
Armando Rodríguez Batista, Deputy Minister of Science, Technology and Environment (Citma), explained to Granma that these norms were the first of a much more comprehensive legal package which continues to be presented (Decree 2/2020 on Advanced Technology Enterprises, Decree Law 7/2020 and its complementary provisions), to guide implementation of policies to perfect Cuba’s science, technology and innovation system, approved by the Council of Ministers in October of 2018.
News »
Clinical trials of Mambisa and Abdala candidate vaccines approved
After a careful review of the information presented, including evidence from pharmaceutical development and studies in animals, the Center for the State Control of Drugs, Equipment and Medical Devices (Cecmed), authorized the clinical trials of two new Cuban candidate vaccines to prevent COVID-19, given the names of Mambisa (CIGB-669) and Abdala (CIGB-66). Trials of the first, created by researchers at the Genetic Engineering and Biotechnology Center (CIGB), affiliated with the BioCubaFarma Enterprise Group
News »
Cuba presents another COVID-19 candidate vaccine
Biotechnology made in Cuba shows its strengths once again. The Center for Genetic Engineering and Biotechnology (CIGB) has submitted the technical file of their first vaccine candidate against COVID-19 to the State Center for the Control of Medicines, Medical Equipment and Devices (CECMED).
News »
The emergence of Soberana 1 is not a chance event
Since the beginning of the Revolution, the priority granted to scientific progress, with emphasis on the training of highly qualified human capital and the creation of research centers in dissimilar branches of knowledge, were essential prerequisites that allowed Cuba to venture into the promising sector of biotechnology in the decade of the 1980s, practically at the same time this industry was emerging in a small group of nations with greater technological development.
News »
BioCen develops secure medium to transport viral samples, a first in Cuba
Researchers at the National Biopreparations Center (BioCen) have developed Cuba’s first secure medium to transport viruses, created for use in the collection and transfer of patients’ nasopharyngeal and oropharyngeal samples for the diagnosis of SARS-COV-2, the COVID-19 causal agent. BioCen achieved and industrially scaled the product in only seven days and, subsequently received its Sanitary Registration from the State Center for the Control of Drugs, Equipment and Medical Devices (Cecmed).
News »
Molecular biology laboratory inaugurated in Ciego de Ávila
With the opening today of a molecular biology laboratory at the Roberto Rodríguez hospital, in the municipality of Morón, in Ciego de Ávila , Cuba brings to 12 facilities of this type that process samples for the detection of the SARS-CoV-2 virus, in as well as three others enlist in Holguín , Matanzas and Isla de la Juventud.
News »
Second group of volunteers join Soberana clinical trials
Twenty more Cubans joined the short history of Soberana 01, the country’s first candidate vaccine against COVID-19, on September 2, according to reports from Naturaleza Secreta. This group, composed of volunteers between 60 and 80 years of age, is the second to receive the first dose of the much awaited vaccine.
News »
Soberana in the first phase of clinical trials
The first stage of clinical trials for the definitive validation of Soberana, the Cuban candidate vaccine authorized to begin this phase, began August 24, with the administration of the product to 20 volunteers, between the age of 19 and 59. Over the course of the week, the safety of the candidate vaccine was evaluated and the findings submitted to the Center for State Control of Medications (Cecmed)
News »
Soberana is Cuba’s, the first candidate vaccine against COVID-19 in Latin America and the Caribbean
A vaccine that exemplifies the development of Cuban science; that places us on the level of economically advanced countries; that honors Comandante en Jefe Fidel Castro Ruz, the principal architect of the country’s biotechnology sector. This is what Soberana is, the first Cuban candidate vaccine against COVID-19 authorized for testing in clinical trials.
News »
Díaz-Canel meets with Cuban scientists working on COVID-19 candidate vaccines
The President of the Republic, Miguel Díaz-Canel Bermúdez, recently held a discussion with a group of scientists working on the development of COVID-19 candidate vaccines, to contain the dangerous illness that has caused the deaths of more than 766,000 persons around the world, 88 in our nation.